Yuko Okuda¹, Daisuke Kudo¹, Koji Okazaki¹, Risen Hirai¹, Akira Tanimura¹, Masataka Takeshita^1,2, Akiyoshi Miwa^1,2 (1.Division of Hematology, Tokyo-Kita Medical Center, 2.International Myeloma Center for Advanced Research and Treatment)

Masahiro Takeuchi¹, Sachiho Aizeki¹, Shuntaro Isogai¹, Yuto Shioiri¹, Shinichiro Matsui¹, Asuka Shibamiya¹, Sanshiro Nakao¹, Arata Ishii¹, Yurie Nagai¹, Tatsuzo Mishina¹, Miki Yamazaki¹, Kensuke Kayamori¹, Kenji Kimura¹, Koji Takaishi¹, Yutaro Hino¹, Nagisa Oshima¹, Shokichi Tsukamoto¹, Shio Mitsukawa^1,2, Yusuke Takeda¹, Naoya Mimura^1,2, Chikako Ohwada¹, Tohru Iseki^1,2, Chiaki Nakaseko^1,3, Emiko Sakaida¹ (1.Department of Hematology, Chiba University Hospital, Chiba, Japan, 2.Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, 3.Department of Hematology, International University of Health and Welfare)

Hirofumi Yokota, Fumiya Ohara, Kenta Motegi, Hiroya Wakabayashi, Shihomi Kuwano, Yuki Takeuchi, Hitomi Sawa, Kotaro Miyao, Yuichiro Inagaki, Masashi Sawa (Anjo Kosei Hospital)

Takanori Nishino, Eri Iwata, Takahiro Nishiyama, Sen Ushida, Masaaki Yuge, Kunio Kitamura (Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya-city, Aichi, Japan)

Michihiro Uchiyama (Dept of Hematol., Suwa Red Cross Hospital, Nagano, Japan)

Keigo Okada¹, Hiroki Fujiwara¹, Tomoyuki Arimatsu¹, Yotaro Motomura¹, Tsuyoshi Katou², Naoki Takezako³, Takashi Kumagai¹ (1.Hematol, Ome Municipal General Hospital, Tokyo, Japan, 2.Orthopedic Surg, Ome Municipal General Hospital, Tokyo, Japan, 3.Hematol, National Disaster Medical Center, Tokyo, Japan)